Does oral dipyridamole reduce complications or deaths in patients with acute myocardial infarction?
Oral dipyridamole provides no clinical benefit in reducing complications or deaths in patients with acute myocardial infarction.
A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups. It is concluded that dipyridamole has no benefit in acute myocardial infarction.
Gent et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: